| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH |
,5
-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social, and sexual behavior of naturally receptive rats1 Department of Psychology2 Department of Biological Sciences3 , The Centers for Neuroscience4 Life Sciences Research 1058, The University at Albany-SUNY, 1400 Washington Avenue, Albany, New York 12222, USA
Correspondence should be addressed to C A Frye; Email: cafrye{at}albany.edu
The progesterone metabolite and neurosteroid, 5
-pregnan-3
-ol-20-one (3
,5
-THP), has actions in the midbrain ventral tegmental area (VTA) to modulate lordosis, but its effects on other reproductively relevant behaviors are not well understood. Effects on exploration, anxiety, and social behavior resulting from inhibition of 3
,5
-THP formation, as well as 3
,5
-THP enhancement, were investigated in the midbrain VTA. Naturally sexually receptive, female rats (n=8–10/group) received infusions aimed at the midbrain VTA of vehicle, PK11195 (an inhibitor of neurosteroidogenesis), and/or indomethacin (an inhibitor of 3
,5
-THP formation from prohormones), and were subsequently infused with vehicle or FGIN 1-27 (a neurosteroidogenesis enhancer). The rats were then assessed in a behavioral battery that examined exploration (open field), anxiety (elevated plus maze), social (social interaction), and sexual (paced mating) behavior. Inhibition of 3
,5
-THP formation decreased exploratory, anti-anxiety, social, and sexual behavior, as well as midbrain 3
,5
-THP levels. Infusions of FGIN 1-27 following 3
,5
-THP inhibition restored these behaviors and midbrain 3
,5
-THP levels to those commensurate with control rats that had not been administered inhibitors. These findings suggest that 3
,5
-THP formation in the midbrain VTA may influence appetitive, as well as consummatory, aspects of mating behavior.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |